CRNX Stock Analysis: Buy, Sell, or Hold?

CRNX - Crinetics Pharmaceuticals, Inc.

PHARMACEUTICAL PREPARATIONS
$33.67
-2.64 (-7.27%) ▼
5d: -5.34%
30d: -23.02%
90d: -31.1%
HOLD
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation

CRNX is down 9.3% this week, but smart money is accumulating calls. Top strike: $30 2026-06-18 with 45 OI. Call ratio: 73% View Scanner →

Strength: 7.0/10

Get Alerted When CRNX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: CRNX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: CRNX is currently trading at $33.67, which is considered oversold relative to its 30-day fair value range of $35.73 to $42.42.

Technical Outlook: Technically, CRNX is in a downtrend. The price is currently testing key support at $33.40. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.3% recently.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $83.50 (+148.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $35.73 - $42.42
Company Quality Score 61/100 (BUY)
Volume Confirmation HIGH
Confidence Score 77.4%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-7.3%)
  • BULLISH: Trading 148.0% below Wall St target ($83.50)
  • CAUTION: Recommendation downgraded due to -5.3% 5-day decline

Fair Price Analysis

30-Day Fair Range $35.73 - $42.42
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $33.40
Resistance Level $38.49
Current Trend Downtrend
Technical data as of Mar 27, 2026

Fundamental Context

Forward P/E (Next Year Est.) -8.25
Wall Street Target $83.50 (+148.0%)
Revenue Growth (YoY) 158.4%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 30, 2026 8:52 AM ET
Data refreshes hourly during market hours. Next update: 9:52 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Richard Scott Struthers SELL 21981 shares 2026-03-16
Stephen F Betz SELL 10612 shares 2026-03-16
Jeff E Knight SELL 9911 shares 2026-03-16

Unlock Insider Activity

See real-time buying/selling by company executives for CRNX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$89 54 HOLD
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$58 53 HOLD
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$84 53 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$119 60 BUY
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$547 42 HOLD

More Analysis for CRNX

CRNX Technical Chart CRNX Price Prediction CRNX Earnings Date CRNX Investment Advisor CRNX Fair Price Analyzer CRNX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals